Comis Symposium – Spring 2026

Robert L. Comis, MD Translational Science Symposium
Susceptibility and Inflammation
May 2, 2026
Baltimore, MD
A highlight of the ECOG-ACRIN Group Meeting

This symposium is named for the ECOG-ACRIN Cancer Research Group’s late Group Co-Chair Robert L. Comis, MD (pictured at left). The potential of translational science to advance cancer diagnosis, prevention, and treatment was a guiding passion for Dr. Comis, and the symposium honors him in this way. Learn more about Dr. Comis here.

Agenda

Welcome

Peter J. O’Dwyer, MD and Mitchell D. Schnall, MD, PhD
ECOG-ACRIN Group Co-Chairs, University of Pennsylvania

Segment 1

Metabolism & Cancer – Honing in on Therapeutic Targets and Timing of Interception
Keith T. Flaherty, MD
Harvard University and the Mass General Cancer Center

Segment 2

Oxylipins: Modulators of the Inflammatory Response
Garrett A. FitzGerald, MD
University of Pennsylvania

Segment 3

Impact of Metabolic Risk Factors on Colorectal Cancer
Mingyang Song, MD, ScD
Harvard University and the Massachusetts General Hospital

Segment 4

AI in Liver Disease: Where We Are and Where We Are Going
Walter R. Witschey, PhD
University of Pennsylvania

Segment 5

GLP-1 Strategies for Breast Cancer Prevention and Interception in Elevated Risk Women
Elizabeth S. McDonald, MD, PhD
University of Pennsylvania

Segment 6: Panel Discussion

Moderator
David A. Mankoff, MD, PhD
University of Pennsylvania/Abramson Cancer Center

Panelists
Segment presenters named above, along with:

John M. Kirkwood, MD
University of Pittsburgh/UPMC Hillman Cancer Center

Download the printed program to read speaker bios.